Aqr Capital Management LLC Akebia Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 141,049 shares of AKBA stock, worth $259,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,049
Holding current value
$259,530
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.94 - $1.55 $132,586 - $218,625
141,049 New
141,049 $186,000
Q2 2022

Aug 15, 2022
BUY
$0.32 - $0.67 $216,864 - $454,061
677,703 Added 367.39%
862,168 $304,000
Q1 2022

May 16, 2022
BUY
$0.72 - $2.93 $73,937 - $300,884
102,691 Added 125.58%
184,465 $132,000
Q4 2021

Feb 14, 2022
BUY
$2.26 - $3.34 $20,349 - $30,073
9,004 Added 12.37%
81,774 $185,000
Q3 2021

Nov 15, 2021
BUY
$2.35 - $3.88 $138,064 - $227,953
58,751 Added 419.08%
72,770 $210,000
Q2 2021

Aug 16, 2021
SELL
$2.83 - $4.2 $71,398 - $105,961
-25,229 Reduced 64.28%
14,019 $53,000
Q1 2021

May 17, 2021
SELL
$2.92 - $5.06 $469,667 - $813,875
-160,845 Reduced 80.39%
39,248 $133,000
Q4 2020

Feb 16, 2021
SELL
$2.22 - $3.78 $371,168 - $631,989
-167,193 Reduced 45.52%
200,093 $560,000
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $330,362 - $1.81 Million
138,227 Added 60.35%
367,286 $922,000
Q2 2020

Aug 17, 2020
BUY
$6.67 - $13.58 $79,613 - $162,090
11,936 Added 5.5%
229,059 $3.11 Million
Q1 2020

May 15, 2020
SELL
$4.1 - $10.24 $329,459 - $822,845
-80,356 Reduced 27.01%
217,123 $1.65 Million
Q4 2019

Feb 14, 2020
BUY
$3.16 - $6.73 $656,357 - $1.4 Million
207,708 Added 231.38%
297,479 $1.88 Million
Q3 2019

Nov 14, 2019
BUY
$3.55 - $5.4 $278,941 - $424,305
78,575 Added 701.81%
89,771 $352,000
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $45,903 - $90,127
11,196 New
11,196 $54,000
Q2 2018

Aug 14, 2018
SELL
$9.15 - $11.34 $206,991 - $256,533
-22,622 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$9.53 - $15.68 $164,001 - $269,837
-17,209 Reduced 43.21%
22,622 $216,000
Q4 2017

Feb 14, 2018
SELL
$14.24 - $19.59 $167,818 - $230,868
-11,785 Reduced 22.83%
39,831 $592,000
Q3 2017

Nov 14, 2017
BUY
$13.06 - $19.67 $674,104 - $1.02 Million
51,616
51,616 $1.02 Million

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $338M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email